Cyclin as A Drug Target and Biomarker (P48136)

Target Name: Cyclin

NCBI ID: P48136

Cyclin

Other Name(s): CCN

Cyclin as A Drug Target and Biomarker

Cyclin is a protein that plays a crucial role in cell division and growth. It is a key component of the mitotic spindle, which pulls the chromosomes during cell division. Cyclins are composed of two subtypes, cyclin D1 and cyclin D2. In this article, we will focus on the nonspecified subtype of cyclin, known as Cyclin (CCN).

Cyclin (CCN) as a drug target

Cyclin (CCN) has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Cyclin (CCN) is a protein that is expressed in various tissues and cells throughout the body, including the brain, pancreas, and gastrointestinal tract. It is involved in cell division and growth, and its levels have been linked to the development and progression of various diseases.

One of the key reasons why Cyclin (CCN) has been identified as a potential drug target is its role in cancer development. Cyclin (CCN) has been shown to promote the growth and survival of various types of cancer cells. It is also involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its role in disease, Cyclin (CCN) has also been shown to have potential therapeutic applications. For example, studies have shown that inhibiting Cyclin (CCN) can lead to a reduction in the growth and survival of cancer cells. This suggests that Cyclin (CCN) may be an effective target for cancer treatments.

Cyclin (CCN) as a biomarker

Cyclin (CCN) has also been used as a biomarker in various studies. The levels of Cyclin (CCN) have been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that Cyclin (CCN) may be a useful biomarker for detecting the presence of these diseases.

In addition to its use as a biomarker, Cyclin (CCN) has also been shown to be involved in the development of certain diseases. For example, studies have shown that Cyclin (CCN) is involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that Cyclin (CCN) may be a potential target for therapies aimed at treating these diseases.

Conclusion

In conclusion, Cyclin (CCN) is a protein that plays a crucial role in cell division and growth. It is also involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, Cyclin (CCN) has been identified as a potential drug target and biomarker. Further research is needed to fully understand the role of Cyclin (CCN) in disease and to develop effective treatments.

Protein Name: Cyclin (nonspecified Subtype)

The "Cyclin Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Cyclin comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets